
Hau Van Phan
Examiner (ID: 8779, Phone: (571)272-6696 , Office: P/3618 )
| Most Active Art Unit | 3618 |
| Art Unit(s) | 3618, 3613, 3615, 3619, 3611 |
| Total Applications | 2398 |
| Issued Applications | 1830 |
| Pending Applications | 100 |
| Abandoned Applications | 497 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17140077
[patent_doc_number] => 20210308088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => LIPID COMPOSITIONS CONTAINING BIOACTIVE FATTY ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/233809
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233809
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233809 | Lipid compositions containing bioactive fatty acids | Apr 18, 2021 | Issued |
Array
(
[id] => 19541862
[patent_doc_number] => 20240358898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => Drug Delivery System for Medical Devices
[patent_app_type] => utility
[patent_app_number] => 18/556142
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556142
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556142 | Drug Delivery System for Medical Devices | Apr 18, 2021 | Pending |
Array
(
[id] => 17050541
[patent_doc_number] => 20210259975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => FORMULATIONS COMPRISING HYDRALAZINE, PRAZOSIN, AND/OR NALTREXONE AND TREATMENTS USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/234593
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/234593 | Formulations comprising hydralazine, prazosin, torsemide, spironolactone, and/or naltrexone and treatments using same | Apr 18, 2021 | Issued |
Array
(
[id] => 17911217
[patent_doc_number] => 20220313612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => POLYLACTIC ACID MICROSPHERE, POLYLACTIC-CO-GLYCOLIC ACID MICROSPHERE AND METHOD OF PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/219179
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219179
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219179 | Polylactic acid microsphere, polylactic-co-glycolic acid microsphere and method of preparing the same | Mar 30, 2021 | Issued |
Array
(
[id] => 16961444
[patent_doc_number] => 20210212943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => Dosage form comprising structured solid-solution framework of sparingly-soluble drug and method for manufacture thereof
[patent_app_type] => utility
[patent_app_number] => 17/207587
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/207587 | Dosage form comprising structured solid-solution framework of sparingly-soluble drug and method for manufacture thereof | Mar 18, 2021 | Issued |
Array
(
[id] => 16930863
[patent_doc_number] => 20210196752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => NON-PYROGENIC PREPARATION COMPRISING NANOPARTICLES SYNTHESIZED BY MAGNETOTACTIC BACTERIA FOR MEDICAL OR COSMETIC APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/198645
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198645
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198645 | Non-pyrogenic preparation comprising nanoparticles synthesized by magnetotactic bacteria for medical or cosmetic applications | Mar 10, 2021 | Issued |
Array
(
[id] => 16930728
[patent_doc_number] => 20210196617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => DEODORANT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/194437
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194437 | Deodorant compositions | Mar 7, 2021 | Issued |
Array
(
[id] => 18232060
[patent_doc_number] => 11596602
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => Biocompatible material
[patent_app_type] => utility
[patent_app_number] => 17/186229
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9524
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17186229
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/186229 | Biocompatible material | Feb 25, 2021 | Issued |
Array
(
[id] => 17034949
[patent_doc_number] => 20210251907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Encased Tamper Resistant Controlled Release Dosage Forms
[patent_app_type] => utility
[patent_app_number] => 17/185221
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185221
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185221 | Encased tamper resistant controlled release dosage forms | Feb 24, 2021 | Issued |
Array
(
[id] => 18672131
[patent_doc_number] => 20230309562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => ANTI-MICROBIAL DISINFECTANT AND METHODS OF USE AND PRODUCTION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/801605
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801605
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801605 | ANTI-MICROBIAL DISINFECTANT AND METHODS OF USE AND PRODUCTION THEREOF | Feb 24, 2021 | Pending |
Array
(
[id] => 17341999
[patent_doc_number] => 20220008330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => Method and System for Manufacturing Oral Soluble Films, Compositions of Oral Soluble Films, Oral Soluble Films Made by Thereby, and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/180419
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180419
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/180419 | Method and System for Manufacturing Oral Soluble Films, Compositions of Oral Soluble Films, Oral Soluble Films Made by Thereby, and Methods of Use Thereof | Feb 18, 2021 | Abandoned |
Array
(
[id] => 16930970
[patent_doc_number] => 20210196859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => Cardiovascular Prostheses
[patent_app_type] => utility
[patent_app_number] => 17/178406
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178406
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178406 | Cardiovascular Prostheses | Feb 17, 2021 | Abandoned |
Array
(
[id] => 16868408
[patent_doc_number] => 20210161875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => TOPICAL RETINOID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/170161
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170161
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/170161 | TOPICAL RETINOID COMPOSITIONS | Feb 7, 2021 | Abandoned |
Array
(
[id] => 17050756
[patent_doc_number] => 20210260190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => FRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY WITH AN OXYGEN THERAPEUTIC
[patent_app_type] => utility
[patent_app_number] => 17/169484
[patent_app_country] => US
[patent_app_date] => 2021-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169484
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169484 | Fractionated radiotherapy and chemotherapy with an oxygen therapeutic | Feb 6, 2021 | Issued |
Array
(
[id] => 16883595
[patent_doc_number] => 20210169790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => FLEECE FOR ORAL PRODUCT WITH RELEASABLE COMPONENT
[patent_app_type] => utility
[patent_app_number] => 17/159701
[patent_app_country] => US
[patent_app_date] => 2021-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17159701
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/159701 | Fleece for oral product with releasable component | Jan 26, 2021 | Issued |
Array
(
[id] => 18496012
[patent_doc_number] => 20230218539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING THE INGREDIENT ROTIGOTINE AND AT LEAST ONE NON-AMINE-RESISTANT SILICONE ADHESIVE
[patent_app_type] => utility
[patent_app_number] => 17/794886
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794886
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/794886 | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING THE INGREDIENT ROTIGOTINE AND AT LEAST ONE NON-AMINE-RESISTANT SILICONE ADHESIVE | Jan 21, 2021 | Pending |
Array
(
[id] => 17272679
[patent_doc_number] => 20210378877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => COMPOSITIONS HAVING CYLINDRICAL VOLUME, METHODS, AND APPLICATORS FOR SEALING INJURIES
[patent_app_type] => utility
[patent_app_number] => 17/148228
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/148228 | COMPOSITIONS HAVING CYLINDRICAL VOLUME, METHODS, AND APPLICATORS FOR SEALING INJURIES | Jan 12, 2021 | Abandoned |
Array
(
[id] => 17783627
[patent_doc_number] => 11406732
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Tunable, controlled-release, urethane-containing elastomers and processes of forming the same
[patent_app_type] => utility
[patent_app_number] => 17/148130
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 33
[patent_no_of_words] => 18346
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148130
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/148130 | Tunable, controlled-release, urethane-containing elastomers and processes of forming the same | Jan 12, 2021 | Issued |
Array
(
[id] => 16805927
[patent_doc_number] => 20210128480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/148320
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148320
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/148320 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Jan 12, 2021 | Issued |
Array
(
[id] => 19423776
[patent_doc_number] => 12083167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Ovotransferrin treatment for the reproductive tract
[patent_app_type] => utility
[patent_app_number] => 17/146859
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4911
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17146859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/146859 | Ovotransferrin treatment for the reproductive tract | Jan 11, 2021 | Issued |